Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya.

Feikin DR, Jagero G, Aura B, Bigogo GM, Oundo J, Beall BW, Karani A, Morpeth S, Njenga MK, Breiman RF.

BMC Infect Dis. 2010 Jun 23;10:186. doi: 10.1186/1471-2334-10-186.

2.

The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K.

AIDS. 1998 Nov 12;12(16):2177-84.

PMID:
9833859
3.

Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.

Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, Bari S, Naheed A, Mannan I, Seraji MH, Ahmed NU, Hassan MS, Huda N, Siddik AU, Quasem I, Islam M, Fatima K, Al-Emran H, Brooks WA, Baqui AH, Breiman RF, Sack D, Luby SP.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S103-13. doi: 10.1086/596543.

4.

Serotype prevalence of occult pneumococcal bacteremia.

Alpern ER, Alessandrini EA, McGowan KL, Bell LM, Shaw KN.

Pediatrics. 2001 Aug;108(2):E23.

PMID:
11483833
5.
6.

High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction.

Conklin LM, Bigogo G, Jagero G, Hampton L, Junghae M, da Gloria Carvalho M, Pimenta F, Beall B, Taylor T, Plikaytis B, Laserson KF, Vulule J, Van Beneden C, Whitney CG, Breiman RF, Feikin DR.

BMC Infect Dis. 2016 Jan 16;16:18. doi: 10.1186/s12879-015-1312-2.

7.

Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination.

Munier AL, de Lastours V, Varon E, Donay JL, Porcher R, Molina JM.

Infection. 2013 Jun;41(3):663-8. doi: 10.1007/s15010-013-0419-x.

PMID:
23404685
8.

Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.

Charfi F, Smaoui H, Kechrid A.

Vaccine. 2012 Dec 31;30 Suppl 6:G18-24. doi: 10.1016/j.vaccine.2012.07.017.

PMID:
23228353
10.

Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.

Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G; Lebanese Inter-Hospital Pneumococcal Surveillance Program..

Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.

PMID:
23228352
11.

Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010.

Feikin DR, Njenga MK, Bigogo G, Aura B, Aol G, Audi A, Jagero G, Muluare PO, Gikunju S, Nderitu L, Balish A, Winchell J, Schneider E, Erdman D, Oberste MS, Katz MA, Breiman RF.

PLoS One. 2012;7(8):e43656. doi: 10.1371/journal.pone.0043656.

12.
13.

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.

Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ.

Ann Intern Med. 2000 Feb 1;132(3):182-90.

PMID:
10651598
14.

Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.

Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, Adegbola RA.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S190-6. doi: 10.1086/596500.

15.

Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006-2009.

Tabu C, Breiman RF, Ochieng B, Aura B, Cosmas L, Audi A, Olack B, Bigogo G, Ongus JR, Fields P, Mintz E, Burton D, Oundo J, Feikin DR.

PLoS One. 2012;7(2):e31237. doi: 10.1371/journal.pone.0031237.

16.

Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network.

Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, Lalitha MK, Steinhoff M, Thomas K.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S123-8. doi: 10.1086/596490.

17.

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, LiƱares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103)..

Arch Intern Med. 2005 Jul 11;165(13):1533-40.

PMID:
16009870
18.

Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.

Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS.

Pediatr Infect Dis J. 2008 Oct;27(10):886-91. doi: 10.1097/INF.0b013e3181734f8f.

PMID:
18776825
19.

Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Hsu KK, Shea KM, Stevenson AE, Pelton SI; Massachusetts Department of Public Health..

Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.

PMID:
19935447
20.

Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco).

Elmdaghri N, Benbachir M, Belabbes H, Zaki B, Benzaid H.

Vaccine. 2012 Dec 31;30 Suppl 6:G46-50. doi: 10.1016/j.vaccine.2012.10.044.

PMID:
23228358
Items per page

Supplemental Content

Support Center